
'I'm a neurologist — here's why dementia is rising and how to reduce your risk'
Dementia cases continue to rise in the U.S., with people over age 55 facing a 42% risk of developing the condition in their lifetime.
A recent study led by Johns Hopkins predicted half a million dementia cases in 2025 and one million per year by 2060.
That doesn't mean people are powerless in reducing their risk, however, according to Dr. Joel Salinas, a behavioral neurologist and associate professor at NYU Grossman School of Medicine.
Salinas joined Fox News Digital in an on-camera interview to discuss what's driving the spike in dementia cases and what behavioral changes could provide some degree of cognitive protection. (See the video at the top of the article.)
One of the biggest factors in the increase is demographics, noted Salinas, who is also the co-founder and chief medical officer of Isaac Health, a virtual memory clinic for brain health and memory issues.
"The baby boomer population, being one of the largest groups, is also the fastest-aging group," he told Fox News Digital. "As we get more and more baby boomers — not just over 65, but into their 70s and 80s — we're going to see more and more of them developing some degree of cognitive impairment due to a plethora of reasons."
Age is indeed the biggest risk factor, he noted.
"After age 65, our risk starts to increase. By the time we get to our 80s, that risk is about one in three," he said. "And then after 85, it starts to go up even higher, to almost one in two."
"We know that individuals who don't have a lot of social engagement are at a higher risk."
The pandemic could have played a role as well, the neurologist said.
"This is still being understood, but it seems like COVID-19 also affected blood vessels in the body and the brain," he said. "So people who already had a vulnerability for developing dementia could have had an acceleration or an earlier presentation."
Research has also shown that loneliness and social isolation can increase one's risk of cognitive decline.
"We know that individuals who don't have a lot of social engagement are at a higher risk," Salinas said.
"There's still a lot being done to figure out, you know, the chicken or the egg — is it that you're developing the disease and you're presenting with symptoms of loneliness earlier than others, or is it the loneliness and social isolation that increases your risk? I think it's probably both."
There is a genetic component of dementia, the neurologist said, but the good news is that it's rare.
"If you think about risks and protective factors like a seesaw, these rare genetic mutations may outweigh anything protective you do, but the nice thing is that because they're rare, the chances are you don't have those risks," he said.
"So you probably have genetic risk that can be outweighed to some degree by protective factors."
A major study published last year in The Lancet found that almost half of dementia cases are potentially preventable with lifestyle modifications.
There are many different factors to address, Salinas said, with proper nutrition and exercise topping the list.
Addressing hearing loss by using a hearing aid can also help keep dementia at bay, according to the neurologist, as can staying socially engaged.
Quitting smoking and limiting alcohol consumption can also boost prevention, as does getting enough quality sleep.
Entering a specific stage of sleep called "slow wave" or "stage three" helps to clear out the buildup of toxic proteins in the brain, Salinas said.
"If someone is having issues with sleep, we send them to see a sleep specialist to do the proper testing," he said. "Obstructive sleep apnea, which is a common sleep disorder, affects blood pressure, heart disease and brain health. And it's something that's treatable."
With any healthy behavior, consistency is key.
"It's about putting the odds in your favor that you'll be less likely to develop one of these conditions, or at least delay the onset of symptoms," Salinas said.
"It's never too late to take them on, but whenever you start them, the more consistent you are with them, the bigger return you'll have."
Salinas cited studies showing that 92% of people with mild cognitive impairment go undiagnosed.
"That's when we really want to intervene — but most of the time, people are being diagnosed when the condition is moderate to severe."
While it can be tricky to distinguish between the regular effects of aging and early signs of dementia, Salinas called out some key differentiators.
"It's about putting the odds in your favor that you'll be less likely to develop one of these conditions, or at least delay the onset of symptoms."
"We have more difficulty with memory and thinking as we get older, but it should never be to the point where it interferes with our day-to-day functioning," he said.
It's normal to experience "blips" once in a while, he said, like forgetting your keys, blanking on the name of a celebrity, or walking into a room and not remembering why you entered.
"But if you're seeing that happen much more frequently over time and it's getting worse, that might suggest there is something neurodegenerative and not just normal or typical aging," Salinas advised.
To help ensure earlier diagnosis and intervention, Salinas recommends speaking with a healthcare provider as soon as atypical symptoms are noticed.
"It's important to take them seriously — but not all doctors or medical providers are the same," he cautioned. "A common story we hear is that people's symptoms get dismissed."
In this case, Salinas suggests getting a second opinion, preferably from a neurology specialist.
"There is more and more that can be done to manage symptoms at the earliest stages," he said.
"And at a minimum, if you do end up having a condition that doesn't have a cure, you'll be empowered with information about your health that will help you make better decisions and plan for the future."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
an hour ago
- Newsweek
Why Are So Many Children Getting Long COVID?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. It's been more than five years since the start of the COVID-19 pandemic, although millions of Americans, including children, are still affected by it today. More than one million Americans died due to the virus, according to the Centers for Disease Control and Prevention (CDC), while many were floored by the infection for weeks or even months. Others developed long COVID, which is recognized as a collection of symptoms that last three months or longer after initial COVID symptoms appear. This can affect many systems in the body and result in a wide range of health complications and symptoms. File photo: a mother holds her daughter while she has a COVID-19 test done in a clinic in Washington. File photo: a mother holds her daughter while she has a COVID-19 test done in a clinic in Washington. Carolyn Kaster/AP A study by Researching COVID to Enhance Recovery (RECOVER) last year found that up to 5.8 million American children now have long COVID. The authors wrote that this means between 10 to 20 percent of children who tested positive with COVID-19 went on to develop the condition. Their findings suggest that long COVID may have surpassed asthma—which around 5 million youngsters have—as the most common chronic condition experienced by American children. However, experts told Newsweek that more detailed research is needed to determine the prevalence of the condition, and discussed why millions of children now have ongoing health complications and symptoms post-COVID infection. Prevalence of Long COVID in Children Children of all ages can develop long COVID and typical symptoms can vary between age groups. Poor appetite, sleep issues and respiratory symptoms such as a cough are usually common in infants, toddlers and preschool-aged children with the condition, while school-aged children are also likely to have neurological symptoms like trouble focusing, fear of specific things or feeling lightheaded, the medical journal site JAMA Network reported. Some children may also experience back or neck pain, headache, stomach pain, vomiting and even behavioral changes. Adolescents may also notice a change or loss in smell or taste and experience pain, fatigue-related symptoms or trouble with their memory, JAMA Network said. It is difficult to pin down exactly how common long COVID really is among those aged under 18 as "prevalence varies between studies due to different clinical definitions, follow-up period and survey methods used," Dr. Akiko Iwasaki, director of the Center for Infection and Immunity at the Yale School of Medicine, told Newsweek. However, she added that "the most robust studies" collectively suggest the number of children who get infected with COVID and then develop long COVID "is higher than the prevalence of asthma in children in the U.S." Also discussing the study, Dr. Lauren Grossman, a professor of medicine at Stanford University, told Newsweek: "The number of children under 18 with asthma ranges from 4.9 million to 6 million depending on the source so it's not an incorrect statement to say that there are more or at least the same number of children with asthma as there are with long COVID." Many children are also going "unrecognized and unsupported," Dr. Rachel Gross, a professor in the department of pediatrics at NYU Langone Health, told Newsweek. She added that this means "identifying long COVID in children, especially young children, can be difficult due to rapid developmental changes and communication limitations." However, Dr. Gerald Teague, a professor of pediatrics at the University of Virginia School of Medicine, said that "there are too few prospective studies to compare estimates of long COVID to asthma in children." "We need to come to consensus on how to precisely diagnose long COVID in children first," he told Newsweek, adding that the National Institutes of Health (NIH) and the federal government should "allocate more funding to antiviral research in children to help clear these confusing issues." Gross also said that the age differences in long COVID symptoms "support that a one-size fits all approach will likely not be sufficient to screen for, identify, and treat children with long COVID." Why Do So Many Children Have Long COVID? One reason long COVID continues to affect millions of American children could be related to vaccinations, according to Grossman. "As vaccinations help prevent long COVID and vaccinations were not available to pediatric patients until long after they were for adults, fewer children had protection," she said. She added that the first vaccines were given to adults in December 2020, while children aged 5 to 11 only received their first vaccination in October 2021. Teague also said that studies have found that the original COVID strain in 2020 was far more likely to result in patients developing long COVID, while more recent strains were "not as likely to be associated with symptoms." Few children being vaccinated amid the first, more symptom-inducing strain of the virus may therefore have contributed to the higher rates of long COVID. Child COVID vaccinations have also recently come into the spotlight as Health Secretary Robert F. Kennedy Jr., who has been vocal in his distrust of the mRNA COVID vaccine, announced last month that the CDC will no longer recommend COVID vaccines for "healthy children and healthy pregnant women." Grossman added that Paxlovid, the antiviral medication used to treat COVID infection, was first authorized in December 2021, but only for those aged 12 and over, or those who weighed more than 88 lbs., meaning younger children did not have access to medication. It is important to note, however, that "the prevalence for long COVID in children appears to be just as high in adults," Iwasaki said. "This suggests that children are not immune to developing long COVID, and that their immune system is also susceptible to being derailed by the virus," she added. Iwasaki said that this could mean that COVID infection "might become persistent or trigger autoimmune diseases in children," and that there could be "other viral infections that happen during childhood that impact long COVID susceptibility." However, she said that more research is needed to better understand the underlying mechanisms of long COVID in youngsters. "We need more awareness so that parents and pediatricians can recognize the signs of long COVID in children better," Iwasaki said. "The relationship between children, their caregivers, and pediatricians is vital to identify and eventually treat this under-recognized condition," Gross said. Grossman said that establishing pediatric-specializing long COVID clinics was vital as currently there are "very few," and that promoting "full vaccination" was also important. While more robust studies are beginning to be done on the issue, it is still difficult to determine the overall impact and severity of long COVID on America's children.


Business Journals
4 hours ago
- Business Journals
Employers: Use these guidelines to create benefits for the modern workforce
It's impossible to forget the disruption of the COVID-19 pandemic. It reshaped how we live and work, forcing companies to rapidly adapt to remote models and prioritize health and safety in new ways. The crisis made one thing clear for employers: Affordable, meaningful health care benefits are vital — not only for supporting employees but also for ensuring long-term business stability. In the post-pandemic workplace, high-deductible health plans (HDHPs) continue to present challenges, especially for hourly and lower-wage workers. Recruiting and retaining top talent now hinges on offering benefits that go beyond basic coverage — they must be affordable, accessible and relevant. Employers are shifting from cutting costs to investing in benefits that support the whole person. A new framework: Mind, body, money To meet the demands of today's workforce, I use a simple yet powerful framework to guide benefits strategy: Mind, body and money. These three pillars reflect the needs of employees and can help employers design plans that truly make a difference. 1. Mind: Prioritizing mental health Mental health challenges spiked during the pandemic, and they haven't gone away. Today, one in five adults report struggling with mental health, while nearly a third say they don't have a primary care provider (PCP), leading to overall poor well-being. Telehealth has provided a lifeline, but access to in-network mental health providers remains limited. The need for robust mental health support has never been greater, and addressing it must be a priority. 2. Body: Access and prevention Roughly a third of Americans lack a primary care provider (PCP), leading many to rely on urgent care instead. This not only drives up claim volume and employer costs but also increases the risk of chronic conditions going undetected. Consider this: nearly 40% of Americans are pre-diabetic, and managing diabetes can cost $8,000-$10,000 per person annually. For an employer with 50 employees, that could mean $200,000 in preventable expenses. It's critical to ensure employees have access to high-quality preventive care at a price they can afford. Prevention isn't just a health strategy — it's a financial one. 3. Money: Real incentives that work A recent survey by Imagine360 found that 25% of employees would accept a pay cut in exchange for better benefits. That's a powerful signal. But incentives must go beyond surface-level perks like gym memberships. Instead, they should encourage real engagement with health care — rewarding participation in preventive care, screenings and chronic condition management. At the same time, health care costs are climbing fast — especially when it comes to prescriptions. GLP-1 medications are up 200%-300% year over year, prompting employers to reassess pharmacy strategies. Real savings start with aligning incentives to promote smart utilization. The retirement factor Older employees are increasingly delaying retirement — not because they want to, but because they can't afford to stop working. 28% regularly find themselves out of money before payday arrives. 60% of full-time employees are stressed about finances. 56% of financially stressed employees spend three or more hours a week thinking about finances. Consultants must help employers address this early with smart retirement planning tools like 401(k) plans and Health Savings Accounts (HSAs). Financial wellness isn't a separate issue — it's deeply tied to mental and physical health. Supporting employees across all three areas helps ensure smoother, more cost-effective transitions into retirement. Implementing reference-based pricing, a sustainable cost strategy Reference-Based Pricing (RBP) has evolved significantly over the years. What was once viewed as a heavy lift for companies and employees is now gaining momentum as a sustainable solution to out-of-control health care costs, and a great experience for employees. Like HSAs, RBP has continued to garner more adoption — and it's delivering real results. With rising health care 'tariffs,' more employers are turning to RBP to regain control. For example, a nursing home with 800-900 employees implemented RBP and saw health care costs drop by 40%. Four years later, they've maintained those savings, and employees have embraced the model.* RBP is particularly effective for companies with high turnover or low plan engagement. It allows employers to lower deductibles and build a more budget-neutral benefits strategy. While switching any health plan carrier requires change management, the right consultants can guide the process and help ensure both employer and employee success. What consultants must do now It's time for consultants to step up. That means vetting vendors rigorously and recommending only those that align with the employer's core goals — whether it's improving retention, reducing costs or boosting care quality. Employees care deeply about their take-home pay and their health. If a benefit strategy isn't working for them, they'll leave. Strong benefits aren't nice to have — they're a competitive advantage and a critical part of your business strategy. Want to talk about building a smarter benefits strategy that works for your team and your budget? Connect with me on LinkedIn.
Yahoo
5 hours ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.